| Patients with previous CABG | Healthy volunteers |
---|---|---|
Demographics | N = 38 | N = 25 |
Age, years (median, IQR) | 66 (60–73) | 34 (30–43) |
Sex, n (% male) | 33 (87) | 13 (52) |
BSA, m2 (median, IQR) | 1.9 (1.7–2.0) | 2.0 (1.8–2.0) |
Co-morbidities | Â | |
 Diabetes, n (%) | 21 (55) |  |
 Hypertension, n (%) | 37 (97) |  |
 Hypercholesterolaemia, n (%) | 33 (87) |  |
Medication | Â | |
 B-blockers, n (%) | 30 (79) |  |
 CCB, n (%) | 9 (24) |  |
 ACE-I/ ARB, n (%) | 34 (90) |  |
 Antiplatelets, n (%) | 37 (97) |  |
Presentation | Â | |
 Typical chest pain | 24 (63) |  |
 Atypical chest pain/dyspnoea | 9 (24) |  |
 NSTEACSa | 5 (13) |  |
Coronary artery bypass graft | Â | |
 Time from CABG, years (median, IQR) | 5 (2–11) |  |
 Total number of grafts per patient, n (%) |  |  |
  Single graft (LIMA to LAD) | 1 (3) |  |
  2× grafts | 4 (10) |  |
  3× grafts | 23 (61) |  |
  4× grafts | 10 (26) |  |
 Vein grafts per patient, n (%) |  |  |
  1×  vein graft | 6 (16) |  |
  2× vein grafts | 21 (55) |  |
  3× vein grafts | 10 (26) |  |
CMR parameters | Â | |
 LVEDVI, ml/m2 | 68 ± 12 | 77 ± 15 |
 LVMI, g/m2 | 54 ± 13 | 52 ± 10 |
 LVEF, % | 62 ± 8 | 66 ± 4 |
 Global stress MBF, ml/g/min | 1.54 ± 0.47 | 2.82 ± 0.61 |
 Global rest MBF, ml/g/min | 0.82 ± 0.21 | 0.90 ± 0.24 |
 Global MPR | 1.94 ± 0.63 | 3.22 ± 0.63 |
 LIMA–LAD (or LAD) stress MBF, ml/g/min | 1.65 ± 0.54 | 3.04 ± 0.69 |
 LIMA–LAD (or LAD) rest MBF, ml/g/min | 0.88 ± 0.22 | 1.04 ± 0.30 |
 LIMA–LAD (or LAD) MPR | 1.92 ± 0.64 | 3.04 ± 0.65 |